These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 33530942
1. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation. Zhou ZF, Zhai W, Yu LN, Sun K, Sun LH, Xing XF, Yan M. BMC Anesthesiol; 2021 Feb 02; 21(1):33. PubMed ID: 33530942 [Abstract] [Full Text] [Related]
2. Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients. Yoshii R, Takahashi Y, Tanaka KA, Kawajiri H, Sawa T, Amaya F, Ogawa S. Br J Anaesth; 2024 Jun 02; 132(6):1211-1218. PubMed ID: 38677950 [Abstract] [Full Text] [Related]
10. A Pharmacokinetic and Plasmin-Generation Pharmacodynamic Assessment of a Tranexamic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass. Strauss ER, Li S, Henderson R, Carpenter R, Guo D, Thangaraju K, Katneni U, Buehler PW, Gobburu JVS, Tanaka KA. J Cardiothorac Vasc Anesth; 2022 Aug 02; 36(8 Pt A):2473-2482. PubMed ID: 35094925 [Abstract] [Full Text] [Related]
13. Safety and efficacy of tranexamic acid in paediatric cardiac surgery: study protocol for a double-blind randomised controlled trial. Zhang Y, Jia Y, Shi J, Yuan S, Wang R, Zhang Z, Wang X, Liu J, Ran J, Zhao Y, Hua Z, Yan J, Li S, Zheng Z, Hu S, Wang Y, Yan F. BMJ Open; 2019 Nov 25; 9(11):e032642. PubMed ID: 31772102 [Abstract] [Full Text] [Related]
14. Increased urokinase and consumption of α2 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay. Longstaff C, Locke M. J Thromb Haemost; 2019 Jan 25; 17(1):195-205. PubMed ID: 30451372 [Abstract] [Full Text] [Related]
16. Tranexamic acid leads to paradoxical coagulation changes during cardiac surgery: a pilot rotational thromboelastometry study. Sharma R, Letson HL, Smith S, Dobson GP. J Surg Res; 2017 Sep 25; 217():100-112. PubMed ID: 28602219 [Abstract] [Full Text] [Related]
17. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery. Kuitunen A, Hiippala S, Vahtera E, Rasi V, Salmenperä M. Acta Anaesthesiol Scand; 2005 Oct 25; 49(9):1272-9. PubMed ID: 16146463 [Abstract] [Full Text] [Related]
18. Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial. Shi J, Zhou C, Liu S, Sun H, Wang Y, Yan F, Pan W, Zheng Z. Am Heart J; 2020 Apr 25; 222():147-156. PubMed ID: 32062173 [Abstract] [Full Text] [Related]
19. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, Perez R, Brouard M, Milena A, Martinez R, Mora ML. Crit Care; 2007 Apr 25; 11(6):R117. PubMed ID: 17988379 [Abstract] [Full Text] [Related]
20. Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery. Miszta A, Ahmadzia HK, Luban NLC, Li S, Guo D, Holle LA, Berger JS, James AH, Gobburu JVS, van den Anker J, de Laat B, Wolberg AS. J Thromb Haemost; 2021 Jan 25; 19(1):221-232. PubMed ID: 33001565 [Abstract] [Full Text] [Related] Page: [Next] [New Search]